Discrepancies in volume: impact of Artemis segmented magnetic resonance imaging, ultrasound, and ExactVu measurements on prostate specific antigen density and National Comprehensive Cancer Network risk stratification
Despite differences in PSA density, choice of fusion biopsy system has minimal clinical impact on risk stratification and any of these studied systems may be used without fear of misrepresenting a patient's disease state.
Authors
- Soum D. Lokeshwar (ORCID: https://orcid.org/0000-0002-5260-766X)
- Maximilian Rabil (ORCID: https://orcid.org/0000-0002-2314-0802)
- Lindsey T Webb (ORCID: https://orcid.org/0009-0006-5003-7049)
- Ankur Choksi (ORCID: https://orcid.org/0000-0001-8174-3698)
- Gabriela M. Diaz (ORCID: https://orcid.org/0000-0002-7931-252X)
- Preston C. Sprenkle (ORCID: https://orcid.org/0000-0003-0502-9294)
Institutions
- Yale University (US)
- VA Connecticut Healthcare System (US)
Publication Details
- Journal
- Editor-in-Chief s Voice List of Authors is an Important Element in a Scientific Publication
- Published
- 2025-01-01
- DOI
- https://doi.org/10.5173/ceju.2024.0249
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00